JP2020514415A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020514415A5 JP2020514415A5 JP2019571803A JP2019571803A JP2020514415A5 JP 2020514415 A5 JP2020514415 A5 JP 2020514415A5 JP 2019571803 A JP2019571803 A JP 2019571803A JP 2019571803 A JP2019571803 A JP 2019571803A JP 2020514415 A5 JP2020514415 A5 JP 2020514415A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- group
- nitrogen
- independently selected
- amino
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022188339A JP2023025110A (ja) | 2017-03-13 | 2022-11-25 | 化合物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1703979.3 | 2017-03-13 | ||
| GB1703979.3A GB2561540A (en) | 2017-03-13 | 2017-03-13 | Chemical compounds |
| PCT/GB2018/050623 WO2018167468A1 (en) | 2017-03-13 | 2018-03-12 | Chemical compounds |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022188339A Division JP2023025110A (ja) | 2017-03-13 | 2022-11-25 | 化合物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020514415A JP2020514415A (ja) | 2020-05-21 |
| JP2020514415A5 true JP2020514415A5 (enExample) | 2021-04-22 |
| JP7239497B2 JP7239497B2 (ja) | 2023-03-14 |
Family
ID=58605540
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019571803A Active JP7239497B2 (ja) | 2017-03-13 | 2018-03-12 | 化合物 |
| JP2022188339A Pending JP2023025110A (ja) | 2017-03-13 | 2022-11-25 | 化合物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022188339A Pending JP2023025110A (ja) | 2017-03-13 | 2022-11-25 | 化合物 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US11345669B2 (enExample) |
| EP (1) | EP3596052B1 (enExample) |
| JP (2) | JP7239497B2 (enExample) |
| KR (1) | KR102581620B1 (enExample) |
| CN (1) | CN110869352B (enExample) |
| AU (1) | AU2018234278B2 (enExample) |
| BR (1) | BR112019018854A2 (enExample) |
| CA (1) | CA3056302A1 (enExample) |
| EA (1) | EA201992152A1 (enExample) |
| ES (1) | ES2928447T3 (enExample) |
| GB (1) | GB2561540A (enExample) |
| IL (1) | IL269204B (enExample) |
| SG (1) | SG11201908228TA (enExample) |
| WO (1) | WO2018167468A1 (enExample) |
| ZA (1) | ZA201906035B (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201712282D0 (en) | 2017-07-31 | 2017-09-13 | Nodthera Ltd | Selective inhibitors of NLRP3 inflammasome |
| CN113660983A (zh) * | 2019-01-25 | 2021-11-16 | 诺瑟拉有限公司 | 氨基甲酸酯衍生物及其用途 |
| US12624010B2 (en) | 2020-06-19 | 2026-05-12 | Ac Immune Sa | Dihydrooxazole and thiourea derivatives modulating the NLRP3 inflammasome pathway |
| EP3984535A1 (en) * | 2020-10-16 | 2022-04-20 | Albert-Ludwigs-Universität Freiburg | Nlrp3 activators for use in the treatment of infectious diseases or cancer by activating nlrp3 inflammasome |
| CN114874135B (zh) * | 2021-02-05 | 2024-03-22 | 西南医科大学 | 一类抗乳腺癌的小分子化合物及其制备方法 |
| CN116143753B (zh) * | 2021-08-26 | 2025-07-08 | 瑞石生物医药有限公司 | Nlrp3抑制剂化合物 |
| JP2025502732A (ja) * | 2021-12-22 | 2025-01-28 | エーシー・イミューン・エス・アー | ジヒドロオキサゾール誘導体化合物 |
| CN116496255B (zh) * | 2022-01-27 | 2026-01-30 | 杭州邦顺制药股份有限公司 | Nlrp3抑制剂 |
| CN115974745B (zh) * | 2022-12-27 | 2025-06-03 | 瑞石生物医药有限公司 | 一类含引达省的化合物及其医药用途 |
| CN116640091A (zh) * | 2023-05-25 | 2023-08-25 | 上海吉奉生物科技有限公司 | 一种Boc-3-（3-吡啶基）- L -丙氨酸的合成方法 |
| AU2024280075A1 (en) | 2023-06-02 | 2025-12-11 | Merck Sharp & Dohme Llc | 5,6-Unsaturated Bicyclic Heterocycles Useful as Inhibitors of Nod-Like Receptor Protein 3 |
| GB202404002D0 (en) | 2024-03-20 | 2024-05-01 | Univ Bristol | Antimicrobial compounds |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BG23537A3 (bg) * | 1973-05-22 | 1977-09-15 | Philargo S.A. | Средство за регулиране растежа на растенията |
| GB1479544A (en) * | 1974-02-07 | 1977-07-13 | American Cyanamid Co | 1,2,3,4-tetrahydro-1-naphthylurea derivatives their preparation and their use |
| DE3522938A1 (de) * | 1985-06-27 | 1987-01-08 | Bayer Ag | Leistungsfoerdernde mittel |
| DE69734773T2 (de) | 1996-08-22 | 2006-07-20 | Warner-Lambert Company Llc | Nicht-peptidische Bombesin-Rezeptor-Antagonisten |
| EP1433779A1 (en) | 2002-12-23 | 2004-06-30 | Jerini AG | Use of nitriles as inhibitors of non-proteolytic enzymes |
| US6846836B2 (en) * | 2003-04-18 | 2005-01-25 | Bristol-Myers Squibb Company | N-substituted phenylurea inhibitors of mitochondrial F1F0 ATP hydrolase |
| CN103145616B (zh) | 2003-06-06 | 2015-09-30 | 菲布罗根有限公司 | 含氮杂芳基化合物及其在增加内源性促红细胞生成素中的用途 |
| WO2007076055A2 (en) * | 2005-12-22 | 2007-07-05 | Entremed, Inc. | Compositions and methods comprising proteinase activated receptor antagonists |
| JP5947724B2 (ja) * | 2009-12-21 | 2016-07-06 | アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル | シクロフィリンの新しいインヒビター及びその使用 |
| GB201018171D0 (en) | 2010-10-28 | 2010-12-08 | Givaudan Sa | Organic compounds |
| WO2012090251A1 (ja) | 2010-12-28 | 2012-07-05 | 川崎重工業株式会社 | 電動車両の加速制御システム |
| JP6313203B2 (ja) | 2011-07-18 | 2018-04-18 | ユニバーシティー オブ ケンタッキー リサーチ ファウンデイションＵｎｉｖｅｒｓｉｔｙ Ｏｆ Ｋｅｎｔｕｃｋｙ Ｒｅｓｅａｒｃｈ Ｆｏｕｎｄａｔｉｏｎ | Ａｌｕ−ｒｎａ誘導変性からの細胞の保護及び細胞保護用阻害剤 |
| US8541577B2 (en) | 2011-11-10 | 2013-09-24 | Allergan, Inc. | Aryl urea derivatives as N-formyl peptide receptors like-1 (FPRL-1) receptor modulators |
| AU2014226001B2 (en) * | 2013-03-06 | 2018-12-06 | Allergan, Inc. | Use of agonists of Formyl peptide receptor 2 for treating dermatological diseases |
| JP6929792B2 (ja) * | 2015-02-16 | 2021-09-01 | ザ ユニバーシティ オブ クィーンズランド | スルホニル尿素及び関連化合物並びにその使用 |
| GB201712282D0 (en) | 2017-07-31 | 2017-09-13 | Nodthera Ltd | Selective inhibitors of NLRP3 inflammasome |
-
2017
- 2017-03-13 GB GB1703979.3A patent/GB2561540A/en not_active Withdrawn
-
2018
- 2018-03-12 AU AU2018234278A patent/AU2018234278B2/en active Active
- 2018-03-12 KR KR1020197029817A patent/KR102581620B1/ko active Active
- 2018-03-12 CA CA3056302A patent/CA3056302A1/en active Pending
- 2018-03-12 CN CN201880031403.9A patent/CN110869352B/zh active Active
- 2018-03-12 EP EP18711668.6A patent/EP3596052B1/en active Active
- 2018-03-12 WO PCT/GB2018/050623 patent/WO2018167468A1/en not_active Ceased
- 2018-03-12 SG SG11201908228T patent/SG11201908228TA/en unknown
- 2018-03-12 JP JP2019571803A patent/JP7239497B2/ja active Active
- 2018-03-12 EA EA201992152A patent/EA201992152A1/ru unknown
- 2018-03-12 US US16/493,816 patent/US11345669B2/en active Active
- 2018-03-12 BR BR112019018854A patent/BR112019018854A2/pt active Search and Examination
- 2018-03-12 ES ES18711668T patent/ES2928447T3/es active Active
-
2019
- 2019-09-09 IL IL269204A patent/IL269204B/en unknown
- 2019-09-12 ZA ZA2019/06035A patent/ZA201906035B/en unknown
-
2022
- 2022-11-25 JP JP2022188339A patent/JP2023025110A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES3036330T3 (en) | Imidazopyridazines as modulators of il-17 | |
| US20240293521A1 (en) | Combination use of wt1 antigen peptide and immunomodulator | |
| US11957657B2 (en) | Combination therapies using immuno-dash inhibitors and PGE2 antagonists | |
| TWI664966B (zh) | 治療性化合物 | |
| KR102630889B1 (ko) | 키나제를 조절하는 화합물의 고형 형태 | |
| TWI696611B (zh) | 甘胺酸醯胺化合物的製造方法 | |
| CN109152771B (zh) | 2-取代的吲唑用于治疗和预防自身免疫疾病的用途 | |
| PH12022550611A1 (en) | Brd9 bifunctional degraders and their methods of use | |
| BR122020006918B1 (pt) | Anticorpo de domínio único anti-stat3 e seu uso, métodos in vitro para medir os níveis do referido anticorpo e para diagnosticar um distúrbio mediado por um componente intracelular, polipeptídeo isolado e composição compreendendo o referido anticorpo ou polipeptídeo isolado | |
| CN116096704A (zh) | 用于治疗癌症的组合疗法 | |
| US20160287605A1 (en) | Combination therapy | |
| RU2016122957A (ru) | Способы применения интерлейкина-10 для лечения заболеваний и расстройств | |
| BR112018003212A2 (en) | diacerein or analogues thereof to inhibit asc expression, nlrp3 expression and / or inflammasome nlrp3 complex formation | |
| BR112019021880A2 (pt) | Terapia de combinação com conjugado anticorpo anti-axl-droga | |
| JP2005538099A5 (enExample) | ||
| EP3846803A2 (en) | Macrocyclic compounds for the treatment of medical disorders | |
| WO2019224774A1 (en) | Heterocyclic amides as rip1 kinase inhibitors | |
| US20180110754A1 (en) | Cenicriviroc for the treatment of fibrosis | |
| WO2018187698A2 (en) | Combination therapies using caspase-1 dependent anticancer agents and pge2 antagonists | |
| JP2022552975A (ja) | 関節リウマチを予防及び／又は治療するためのニコチンアミドモノヌクレオチド（ｎｍｎ）の使用、並びに対応する組成物 | |
| WO2022087719A1 (en) | Methods of treating spondyloarthritis or symptoms thereof | |
| US12171729B2 (en) | Formulations of terameprocol and temozolomide and their use in stimulation of humoral immunity in tumors | |
| KR102308146B1 (ko) | 항암제에 의해 유도되는 이질통의 예방 또는 치료용 조성물 및 이를 이용한 치료방법 | |
| WO2018156950A1 (en) | Compositions and methods for restoring the immune system | |
| WO2025235814A1 (en) | Potent asgpr-binding heterobifuctional compounds for the degradation of targeted extracellular proteins |